Caption Management, LLC Kura Oncology, Inc. Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $1.07 Million - $1.55 Million	111,023 New	111,023 $1.17 Million
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $572,792 - $980,325	-53,482 Reduced 82.28%	11,518 $211,000
Q1 2022 May 13, 2022	SELL	$11.78 - $16.98 $1.08 Million - $1.56 Million	-92,000 Reduced 58.6%	65,000 $1.05 Million
Q4 2021 Feb 11, 2022	BUY	$12.22 - $19.57 $1.86 Million - $2.98 Million	152,400 Added 3313.04%	157,000 $2.2 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $95,910 - $137,448	4,600 New	4,600 $96,000
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $702,652 - $1.11 Million	-28,390 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $823,310 - $1.18 Million	28,390 New	28,390 $927,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.